We’re delighted to welcome Elisa Cascade to the ACRP Board of Trustees. Throughout her career she’s demonstrated an extraordinary ability to turn her vision of improving clinical operations into reality.
PHILADELPHIA and LONDON (PRWEB)
December 14, 2017
Visionary clinical trials technologist and self-professed “data geek” Elisa Cascade continues to amass industry distinctions as DrugDev, an IQVIA company, announced Cascade’s election to the Association of Clinical Research Professionals (ACRP) Board of Trustees. The volunteer-based, member-elected Board carries out the ACRP’s mission to drive excellence in the conduct of clinical research.
Cascade, who is responsible for the growth and development of the DrugDev Spark™ clinical operations suite, also is the architect of the DrugDev Golden Number, the industry’s universal identifier for site facilities and personnel used by the Investigator Databank, the TransCelerate Investigator Registry, and leading pharma companies and CROs.
With over 25 years of pharma clinical research experience as well as expertise in market research, brand strategy, sales force development, and pricing, Cascade works closely with sponsors and sites to improve clinical trial operations through standardization, industry-wide collaboration, and a beautiful technology experience.
ACRP Executive Director Jim Kremidas said, “We’re delighted to welcome Elisa Cascade to the ACRP Board of Trustees. Throughout her career she’s demonstrated an extraordinary ability to turn her vision of improving clinical operations into reality. We’re thrilled to welcome Elisa and look forward to seeing how her ideas and expertise help enhance the Association, our members’ careers…